Neurocrine Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $512.4M | $993.2M | $141.7M |
| FY2019 | $669.1M | $1.31B | $112.3M |
| FY2020 | $608.5M | $1.73B | $187.1M |
| FY2021 | $698.5M | $2.07B | $340.8M |
| FY2022 | $660.9M | $2.37B | $262.9M |